News Focus
News Focus
Followers 65
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: biopharm post# 156943

Friday, 01/17/2014 7:57:20 PM

Friday, January 17, 2014 7:57:20 PM

Post# of 347009
Thanks bio...From Paul.."We are "uniquely" positioned with our later stage pipeline of first-in-class therapeutics..."

Is Cotara first in class as well?
I still say the "we" keep it.
Great Life Saving Potential, unique, HIGH $ paid by insurance(orphan status), Notoriety/Marketing Impact..WE MAKE IT....

Enjoy the weekend all....

wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y